Selected Recent TB Articles/Publications
Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis in BMJ
Drug-associated Adverse Events in the Treatment of Multidrug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis in Lancet Respir Med
COVID-19 and tuberculosis in South Africa: A dangerous combination in SAMJ
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 in MMWR Recomm Rep
User experience and patient satisfaction with tuberculosis care in low- and middle-income countries: A systematic review in J Clin Tuberc Other Mycobact Dis
Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis in Int J Tuber Lung Dis
Treatment with Isoniazid or Rifampin for Latent Tuberculosis Infection: Population-Based Study of Hepatotoxicity, Completion, and Costs in Eur Respir J
Isoniazid-resistant tuberculosis: A problem we can no longer ignore in Plos Medicine
Tuberculosis case fatality in India: a systematic review and meta-analysis in BMJ GH.
Deep learning, computer-aided radiography reading for tuberculosis: a diagnostic accuracy study from a tertiary hospital in India in Scientific Reports
Identifying gaps in the quality of latent tuberculosis infection care in J Clin Tuberc Other Mycobact Dis
Standardised shorter regimens versus individualised longer regimens for multidrug-resistant TB in Eur Respir J.
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials. in Lancet Infect Dis.
Estimating treatment importance in multidrug-resistant tuberculosis using Targeted Learning: An observational individual patient data network meta-analysis in Biometrics
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial in BMJ Open.
Initiative for Promoting Affordable and Quality Tuberculosis Tests (IPAQT): a market-shaping intervention in India in BMJ GH.
Editorial: Evolving Mechanisms of Disease Tolerance. in Front Immunol.
Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis in Emerg Infect Dis.